FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Guidance on Aluminum Content in Parenteral Drugs

FDA issues a draft guidance entitled Small Volume Parenteral Drug Products and Pharmacy Bulk Packages for Parenteral Nutrition: Aluminum Content and L...

latest-news-card-1
FDA General

FDA Elsa Rollout a Nuanced Dance: Consultant

Consultant Erika Roberts says FDAs rollout of its staff AI tool Elsa is a good first step, but much more needs to be done to reach the potential of us...

Medical Devices

Sirtex Medical Wins Device OK for Liver Cancer

FDA approves a Sirtex Medical PMA for its SIR-Spheres Y-90 resin microspheres for treating unresectable hepatocellular carcinoma.

Biologics

Vacate RFK Jr. Covid Vaccine Recommendations: Lawsuit

A group of medical societies files suit against HHS secretary Robert F. Kennedy Jr. and FDA commissioner Marty Makary to reverse a 5/27 decision to re...

latest-news-card-1
Human Drugs

Report Highlights Study Demographic Representation

A new FDA report examines the demographic representation of clinical trials supporting the approval of 50 novel drug therapies last year.

latest-news-card-1
Human Drugs

REMS Requirements Ended for CAR T Cell Therapies

FDA removes risk evaluation and mitigation strategies requirements for all currently approved CAR T cell therapies, saying the programs have burdened ...

latest-news-card-1
Human Drugs

UCB Positive Data for Epileptic Encephalopathy Drug

UCB reports positive data from a Phase 3 clinical trial evaluating fenfluramine as an adjunctive treatment for rare epileptic encephalopathy condition...

latest-news-card-1
Human Drugs

Appeals Court Backs FDAs Sameness Interpretation

An appeals court rules for FDA that a clinically superior drug is not the same as a drug that is otherwise the same.

latest-news-card-1
Human Drugs

NDA Filed for Nicotine Dependence Drug

Achieve Life Sciences files an NDA for cytisinicline for treating nicotine dependence as part of smoking cessation in adults.

latest-news-card-1
Human Drugs

Livmarli, Bylvay Get Liver Injury/Bleeding Updates

FDA issues safety-related labeling updates for two bile acid transport inhibitors Mirum Pharmaceuticals Livmarli and Ipsen Biopharmaceuticals Bylvay ...